AU3702995A - Immunomodulatory polypeptides - Google Patents

Immunomodulatory polypeptides

Info

Publication number
AU3702995A
AU3702995A AU37029/95A AU3702995A AU3702995A AU 3702995 A AU3702995 A AU 3702995A AU 37029/95 A AU37029/95 A AU 37029/95A AU 3702995 A AU3702995 A AU 3702995A AU 3702995 A AU3702995 A AU 3702995A
Authority
AU
Australia
Prior art keywords
immunomodulatory polypeptides
immunomodulatory
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37029/95A
Inventor
Janos Gergely
Denis Raymond Stanworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of AU3702995A publication Critical patent/AU3702995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37029/95A 1994-10-20 1995-10-20 Immunomodulatory polypeptides Abandoned AU3702995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421180A GB9421180D0 (en) 1994-10-20 1994-10-20 Immunomodulatory Polypeptides
GB9421180 1994-10-20
PCT/GB1995/002487 WO1996012739A1 (en) 1994-10-20 1995-10-20 Immunomodulatory polypeptides

Publications (1)

Publication Number Publication Date
AU3702995A true AU3702995A (en) 1996-05-15

Family

ID=10763148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37029/95A Abandoned AU3702995A (en) 1994-10-20 1995-10-20 Immunomodulatory polypeptides

Country Status (3)

Country Link
AU (1) AU3702995A (en)
GB (1) GB9421180D0 (en)
WO (1) WO1996012739A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724239B (en) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 Bioactive peptide with amino acid structure NKELDPVQKLFVDKIREYK and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563212A1 (en) * 1990-11-23 1993-10-06 Immunodynamics, Inc. Synthetic immunoactive peptides having immunomodulating and therapeutic activities
ATE188219T1 (en) * 1991-10-28 2000-01-15 Cytran Ltd PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE.

Also Published As

Publication number Publication date
WO1996012739A1 (en) 1996-05-02
GB9421180D0 (en) 1994-12-07

Similar Documents

Publication Publication Date Title
AU4370596A (en) Novel hedgehog-derived polypeptides
EP1256352A3 (en) Immunomodulatory peptides
AU2832295A (en) Cytoanalyzer
AU4307497A (en) Immunomodulatory formulation
AU4131596A (en) Polyglycomers
AU2131195A (en) Prophenins - antibiotic peptides
AU5166296A (en) New peptides with immunomodulatory effects
AU1987695A (en) Immunomodulatory trichinella substances
AU7469594A (en) Poop-scoop
AUPM489194A0 (en) Peptides
AU2532895A (en) Sensor
AU3166195A (en) Acylimidazopyridines
AU2803595A (en) Immunodominant polypeptides
AU6476398A (en) Novel peptides
AU3446995A (en) Biodestumping
AU3702995A (en) Immunomodulatory polypeptides
AU2610095A (en) Sensor
AU2411395A (en) Hydrocopter
AU2532795A (en) Sensor arrangement
AU2045895A (en) Novel polypeptides
AU1588395A (en) Handwear
AUPM374794A0 (en) Compartmentalizer
AU2131995A (en) Peptides
AUPM334694A0 (en) Novel peptides
AU2003200038A1 (en) Human chemokine polypeptides